644 related articles for article (PubMed ID: 330565)
1. Phytohemagglutinin response in systemic lupus erythematosus. Reconstitution experiments using highly purified lymphocyte subpopulations and monocytes.
Utsinger PD; Yount WJ
J Clin Invest; 1977 Sep; 60(3):626-38. PubMed ID: 330565
[TBL] [Abstract][Full Text] [Related]
2. Characterization of T lymphocyte subpopulations responsible for deficient interleukin 2 activity in patients with systemic lupus erythematosus.
Murakawa Y; Takada S; Ueda Y; Suzuki N; Hoshino T; Sakane T
J Immunol; 1985 Jan; 134(1):187-95. PubMed ID: 3917275
[TBL] [Abstract][Full Text] [Related]
3. Suppressor-cell dysfunction in systemic lupus erythematosus. Cells involved and in vitro correction.
Sagawa A; Abdou NI
J Clin Invest; 1978 Oct; 62(4):789-96. PubMed ID: 308952
[TBL] [Abstract][Full Text] [Related]
4. Mononuclear phagocytes from patients with active systemic lupus erythematosus down-regulate the specific in vitro reactivity of autologous lymphocytes to double-stranded DNA.
Weill BJ; Renoux ML
Clin Exp Immunol; 1988 Apr; 72(1):43-9. PubMed ID: 3293851
[TBL] [Abstract][Full Text] [Related]
5. Defective monocyte production of, and T lymphocyte response to, interleukin-1 in the peripheral blood of patients with systemic lupus erythematosus.
Alcocer-Varela J; Laffon A; Alarcón-Segovia D
Clin Exp Immunol; 1984 Jan; 55(1):125-32. PubMed ID: 6229371
[TBL] [Abstract][Full Text] [Related]
6. Suppressor function of peripheral blood mononuclear cells in normal individuals and in patients with systemic lupus erythematosus.
Bresnihan B; Jasin HE
J Clin Invest; 1977 Jan; 59(1):106-16. PubMed ID: 830659
[TBL] [Abstract][Full Text] [Related]
7. Epstein-Barr virus induces normal B cell responses but defective suppressor T cell responses in patients with systemic lupus erythematosus.
Tsokos GC; Magrath IT; Balow JE
J Immunol; 1983 Oct; 131(4):1797-801. PubMed ID: 6311898
[TBL] [Abstract][Full Text] [Related]
8. Phagocyte function and cell-mediated immunity in systemic lupus erythematosus.
Landry M
Arch Dermatol; 1977 Feb; 113(2):147-54. PubMed ID: 300001
[TBL] [Abstract][Full Text] [Related]
9. Nuclear DNA degradation in lymphocytes of patients with systemic lupus erythematosus.
Compton LJ; Steinberg AD; Sano H
J Immunol; 1984 Jul; 133(1):213-6. PubMed ID: 6725954
[TBL] [Abstract][Full Text] [Related]
10. Expression and function of inducible co-stimulator in patients with systemic lupus erythematosus: possible involvement in excessive interferon-gamma and anti-double-stranded DNA antibody production.
Kawamoto M; Harigai M; Hara M; Kawaguchi Y; Tezuka K; Tanaka M; Sugiura T; Katsumata Y; Fukasawa C; Ichida H; Higami S; Kamatani N
Arthritis Res Ther; 2006; 8(3):R62. PubMed ID: 16563187
[TBL] [Abstract][Full Text] [Related]
11. [Serum factors inhibiting cellular immunity in systemic lupus erythematosus].
Lavalle C; Alcocer J; Gudiño J; Fraga A
Prensa Med Mex; 1978; 43(1-2):16-20. PubMed ID: 309127
[TBL] [Abstract][Full Text] [Related]
12. Selective depression of the xenogeneic cell-mediated lympholysis in systemic lupus erythematosus.
Charpentier B; Carnaud C; Bach JF
J Clin Invest; 1979 Aug; 64(2):351-60. PubMed ID: 110833
[TBL] [Abstract][Full Text] [Related]
13. [Suppressor hyperactivity in relation to allogeneic lymphocyte proliferation as a manifestation of T- T-cell interaction defects in systemic lupus erythematosus].
Stenina MA; Potapova AA; Biriukov AV; Skripnik AIu; Cheredeev AH
Biull Eksp Biol Med; 1986 Aug; 102(8):215-7. PubMed ID: 2874848
[TBL] [Abstract][Full Text] [Related]
14. Roles of CCR2 and CXCR3 in the T cell-mediated response occurring during lupus flares.
Amoura Z; Combadiere C; Faure S; Parizot C; Miyara M; Raphaël D; Ghillani P; Debre P; Piette JC; Gorochov G
Arthritis Rheum; 2003 Dec; 48(12):3487-96. PubMed ID: 14673999
[TBL] [Abstract][Full Text] [Related]
15. Depressed primary in vitro antibody response in untreated systemic lupus erythematosus. T helper cell defect and lack of defective suppressor cell function.
Delfraissy JF; Segond P; Galanaud P; Wallon C; Massias P; Dormont J
J Clin Invest; 1980 Jul; 66(1):141-8. PubMed ID: 6447163
[TBL] [Abstract][Full Text] [Related]
16. Modulation of the immunoreactivity of a T-lymphocyte subpopulation by neutrophil-released prostaglandin.
Niwa Y; Sakane T; Fukuda Y; Miyachi Y; Kanoh T
J Clin Lab Immunol; 1985 May; 17(1):37-44. PubMed ID: 2931529
[TBL] [Abstract][Full Text] [Related]
17. Study of lymphocyte subpopulations in normal humans and patients with systemic lupus erythematosus by fractionation of peripheral blood lymphocytes on a discontinuous Ficoll gradient.
Glinski W; Gershwin ME; Budman DR; Steinberg AD
Clin Exp Immunol; 1976 Nov; 26(2):228-38. PubMed ID: 1086753
[TBL] [Abstract][Full Text] [Related]
18. Lymphocyctes Tgammadelta in clinically normal skin and peripheral blood of patients with systemic lupus erythematosus and their correlation with disease activity.
Robak E; Niewiadomska H; Robak T; Bartkowiak J; Błoński JZ; Woźniacka A; Pomorski L; Sysa-Jedrezejowska A
Mediators Inflamm; 2001 Aug; 10(4):179-89. PubMed ID: 11577994
[TBL] [Abstract][Full Text] [Related]
19. Correlation of T and B cell activities in vitro and serum IL-2 levels in systemic lupus erythematosus.
Huang YP; Perrin LH; Miescher PA; Zubler RH
J Immunol; 1988 Aug; 141(3):827-33. PubMed ID: 3135313
[TBL] [Abstract][Full Text] [Related]
20. Impaired immunoregulation in systemic lupus erythematosus: defective adenosine-induced suppressor T lymphocyte generation.
Kammer GM; Birch RE; Polmar SH
J Immunol; 1983 Apr; 130(4):1706-12. PubMed ID: 6220065
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
